• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳腺癌的基因进化过程中,染色体重排和癌基因扩增先于非整倍体化出现。

Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.

作者信息

Rennstam K, Baldetorp B, Kytölä S, Tanner M, Isola J

机构信息

Department of Oncology, Jubileum Institute, University Hospital, Lund, Sweden.

出版信息

Cancer Res. 2001 Feb 1;61(3):1214-9.

PMID:11221853
Abstract

Breast carcinoma is thought to arise because of multiple successive changes in the genome of the normal epithelial cells. However, little is known of the order of appearance of different types of genetic aberrations We studied the ERBB2 (Her-2/neu) and CCND1 (cyclin D1) oncogene amplification in flow cytometrically sorted diploid and nondiploid tumor cell populations by fluorescence in situ hybridization (FISH). The purity of the cell sorting was confirmed by static DNA image cytometry. Spectral karyotyping was used to define differences in a genome-wide manner between two distinctly different aneuploid cell clones found in each of two breast cancer cell lines. FISH indicated the presence of gene amplification both in diploid and nondiploid cell clones in 17 of the 21 amplification-containing tumors analyzed. The oncogene copy numbers remained unchanged throughout aneuploidization in 11 of 17 tumors. The remaining six tumors showed an increase in oncogene copy number as well as the number of chromosome 11 or 17 centromeres (the original location of CCNDI and ERBB2, respectively). Breast carcinoma cell lines MDA-157 and MDA-436 showed a significant number of chromosomal rearrangements in the near-diploid clones, which were present in duplicate in the corresponding aneuploid (polyploid) clones. These results indicate that ploidy shift, ie., aneuploidization, in breast cancer is a late genetic event which is preceded by both oncogene amplifications as well as many chromosomal rearrangements.

摘要

乳腺癌被认为是由于正常上皮细胞基因组中多次连续变化而产生的。然而,对于不同类型基因畸变出现的顺序知之甚少。我们通过荧光原位杂交(FISH)研究了流式细胞术分选的二倍体和非二倍体肿瘤细胞群体中的ERBB2(Her-2/neu)和CCND1(细胞周期蛋白D1)癌基因扩增情况。通过静态DNA图像细胞术确认了细胞分选的纯度。光谱核型分析用于以全基因组方式定义在两个乳腺癌细胞系中各自发现的两个明显不同的非整倍体细胞克隆之间的差异。FISH表明,在分析的21个含有扩增的肿瘤中的17个中,二倍体和非二倍体细胞克隆中均存在基因扩增。在17个肿瘤中的11个中,癌基因拷贝数在整个非整倍体化过程中保持不变。其余6个肿瘤显示癌基因拷贝数以及11号或17号染色体着丝粒数量增加(分别是CCNDI和ERBB2的原始位置)。乳腺癌细胞系MDA-157和MDA-436在近二倍体克隆中显示出大量染色体重排,这些重排在相应的非整倍体(多倍体)克隆中以重复形式存在。这些结果表明,乳腺癌中的倍性转变,即非整倍体化,是一种晚期遗传事件,在此之前既有癌基因扩增,也有许多染色体重排。

相似文献

1
Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.在乳腺癌的基因进化过程中,染色体重排和癌基因扩增先于非整倍体化出现。
Cancer Res. 2001 Feb 1;61(3):1214-9.
2
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.亚二倍体乳腺癌中的基因畸变:4号染色体频繁缺失及细胞周期蛋白D1癌基因扩增。
Am J Pathol. 1998 Jul;153(1):191-9. doi: 10.1016/S0002-9440(10)65560-5.
3
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.乳腺癌中拓扑异构酶IIα基因扩增与缺失的特征分析
Genes Chromosomes Cancer. 1999 Oct;26(2):142-50.
4
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.通过cDNA微阵列在乳腺癌的ERBB2扩增子中发现的新的扩增且高表达基因。
Cancer Res. 2001 Nov 15;61(22):8235-40.
5
Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.乳头佩吉特病:ERBB2和CCND1基因的拷贝数与ERBB-2蛋白和细胞周期蛋白D1的表达情况
Neoplasma. 2003;50(6):396-402.
6
[Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].[乳腺浸润性导管癌:应用荧光原位杂交(FISH)技术研究CCND1基因和11号染色体的拷贝数,并与免疫组织化学检测细胞周期蛋白D1蛋白和雌激素受体(ERα)的表达进行比较]
Cas Lek Cesk. 2002 Nov 8;141(22):708-14.
7
Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.通过荧光原位杂交检测前列腺癌中低水平HER-2/neu基因扩增
Cancer J. 2001 Sep-Oct;7(5):395-403.
8
Aneuploidy in breast cancer: a fluorescence in situ hybridization study.乳腺癌中的非整倍体:一项荧光原位杂交研究。
Cytometry. 1995 Dec 15;22(4):282-91. doi: 10.1002/cyto.990220404.
9
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.显示ERBB2过表达的乳腺癌肿瘤中17号染色体多体性:一项使用荧光原位杂交和免疫组织化学对175例病例的研究
Breast Cancer Res. 2005;7(2):R267-73. doi: 10.1186/bcr996. Epub 2005 Jan 26.
10
Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.通过对染色体畸变的高分辨率断点分析鉴定转化乳腺细胞中的新型基因重排。
Endocr Relat Cancer. 2010 Jan 29;17(1):87-98. doi: 10.1677/ERC-09-0065. Print 2010 Mar.

引用本文的文献

1
Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer.根据雌激素受体α(ERα)状态,基因拷贝数作为乳腺癌对标准治疗药物反应的标志物
Breast Cancer (Dove Med Press). 2024 Mar 15;16:127-139. doi: 10.2147/BCTT.S445753. eCollection 2024.
2
Cell division cycle proteinising prognostic biomarker of breast cancer.细胞分裂周期蛋白作为乳腺癌的预后生物标志物。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20191227.
3
ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway.
ZFP57 通过下调 MEST 介导的 Wnt/β-连环蛋白信号通路抑制乳腺癌细胞增殖。
Cell Death Dis. 2019 Feb 20;10(3):169. doi: 10.1038/s41419-019-1335-5.
4
The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.c-Myc-RBM38 环路在乳腺癌生长抑制中的作用。
J Exp Clin Cancer Res. 2017 Apr 11;36(1):49. doi: 10.1186/s13046-017-0521-5.
5
The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.肝癌与细胞周期之间的复杂关系:一个多方调控的故事。
Cancers (Basel). 2014 Jan 13;6(1):79-111. doi: 10.3390/cancers6010079.
6
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.基因组结构特征可描绘乳腺癌患者肿瘤进展路径和命运。
Sci Transl Med. 2010 Jun 30;2(38):38ra47. doi: 10.1126/scitranslmed.3000611.
7
The Rad1-Rad10 complex promotes the production of gross chromosomal rearrangements from spontaneous DNA damage in Saccharomyces cerevisiae.Rad1-Rad10复合物促进酿酒酵母中由自发DNA损伤导致的大规模染色体重排的产生。
Genetics. 2005 Apr;169(4):1927-37. doi: 10.1534/genetics.104.039768. Epub 2005 Jan 31.
8
Increased genome instability and telomere length in the elg1-deficient Saccharomyces cerevisiae mutant are regulated by S-phase checkpoints.在elg1缺陷型酿酒酵母突变体中,基因组不稳定性增加和端粒长度受S期检查点调控。
Eukaryot Cell. 2004 Dec;3(6):1557-66. doi: 10.1128/EC.3.6.1557-1566.2004.
9
Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.组织学正常的乳腺上皮中的杂合性缺失或等位基因失衡与共存癌中的杂合性缺失或等位基因失衡不同。
Am J Pathol. 2002 Jul;161(1):283-90. doi: 10.1016/S0002-9440(10)64180-6.
10
Centrosome amplification drives chromosomal instability in breast tumor development.中心体扩增在乳腺肿瘤发生发展过程中驱动染色体不稳定。
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1978-83. doi: 10.1073/pnas.032479999. Epub 2002 Feb 5.